190 related articles for article (PubMed ID: 20436219)
1. Bile acids are multifunctional modulators of the Barrett's carcinogenesis.
Burnat G; Majka J; Konturek PC
J Physiol Pharmacol; 2010 Apr; 61(2):185-92. PubMed ID: 20436219
[TBL] [Abstract][Full Text] [Related]
2. Bile acids induce overexpression of homeobox gene CDX-2 and vascular endothelial growth factor (VEGF) in human Barrett's esophageal mucosa and adenocarcinoma cell line.
Burnat G; Rau T; Elshimi E; Hahn EG; Konturek PC
Scand J Gastroenterol; 2007 Dec; 42(12):1460-5. PubMed ID: 17852856
[TBL] [Abstract][Full Text] [Related]
3. In Barrett's esophagus patients and Barrett's cell lines, ursodeoxycholic acid increases antioxidant expression and prevents DNA damage by bile acids.
Peng S; Huo X; Rezaei D; Zhang Q; Zhang X; Yu C; Asanuma K; Cheng E; Pham TH; Wang DH; Chen M; Souza RF; Spechler SJ
Am J Physiol Gastrointest Liver Physiol; 2014 Jul; 307(2):G129-39. PubMed ID: 24852569
[TBL] [Abstract][Full Text] [Related]
4. Guggulsterone, a plant-derived inhibitor of NF-TB, suppresses CDX2 and COX-2 expression and reduces the viability of esophageal adenocarcinoma cells.
Yamada T; Osawa S; Ikuma M; Kajimura M; Sugimoto M; Furuta T; Iwaizumi M; Sugimoto K
Digestion; 2014; 90(3):208-17. PubMed ID: 25427631
[TBL] [Abstract][Full Text] [Related]
5. Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-κB activation in benign Barrett's epithelial cells.
Huo X; Juergens S; Zhang X; Rezaei D; Yu C; Strauch ED; Wang JY; Cheng E; Meyer F; Wang DH; Zhang Q; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2011 Aug; 301(2):G278-86. PubMed ID: 21636532
[TBL] [Abstract][Full Text] [Related]
6. The bile acid deoxycholic acid (DCA) at neutral pH activates NF-kappaB and induces IL-8 expression in oesophageal cells in vitro.
Jenkins GJ; Harries K; Doak SH; Wilmes A; Griffiths AP; Baxter JN; Parry JM
Carcinogenesis; 2004 Mar; 25(3):317-23. PubMed ID: 14656946
[TBL] [Abstract][Full Text] [Related]
7. Opposing effects of bile acids deoxycholic acid and ursodeoxycholic acid on signal transduction pathways in oesophageal cancer cells.
Abdel-Latif MM; Inoue H; Reynolds JV
Eur J Cancer Prev; 2016 Sep; 25(5):368-79. PubMed ID: 26378497
[TBL] [Abstract][Full Text] [Related]
8. Factors regulating nuclear factor-kappa B activation in esophageal cancer cells: Role of bile acids and acid.
Abdel-Latif MM; Inoue H; Kelleher D; Reynolds JV
J Cancer Res Ther; 2016; 12(1):364-73. PubMed ID: 27072265
[TBL] [Abstract][Full Text] [Related]
9. Ursodeoxycholic acid inhibits interleukin 1 beta [corrected] and deoxycholic acid-induced activation of NF-kappaB and AP-1 in human colon cancer cells.
Shah SA; Volkov Y; Arfin Q; Abdel-Latif MM; Kelleher D
Int J Cancer; 2006 Feb; 118(3):532-9. PubMed ID: 16106402
[TBL] [Abstract][Full Text] [Related]
10. NF-kappaB activation in esophageal adenocarcinoma: relationship to Barrett's metaplasia, survival, and response to neoadjuvant chemoradiotherapy.
Abdel-Latif MM; O'Riordan J; Windle HJ; Carton E; Ravi N; Kelleher D; Reynolds JV
Ann Surg; 2004 Apr; 239(4):491-500. PubMed ID: 15024310
[TBL] [Abstract][Full Text] [Related]
11. The bile acid deoxycholic acid has a non-linear dose response for DNA damage and possibly NF-kappaB activation in oesophageal cells, with a mechanism of action involving ROS.
Jenkins GJ; Cronin J; Alhamdani A; Rawat N; D'Souza F; Thomas T; Eltahir Z; Griffiths AP; Baxter JN
Mutagenesis; 2008 Sep; 23(5):399-405. PubMed ID: 18515815
[TBL] [Abstract][Full Text] [Related]
12. Effect of adiponectin and ghrelin on apoptosis of Barrett adenocarcinoma cell line.
Konturek PC; Burnat G; Rau T; Hahn EG; Konturek S
Dig Dis Sci; 2008 Mar; 53(3):597-605. PubMed ID: 17763959
[TBL] [Abstract][Full Text] [Related]
13. NO-releasing aspirin exerts stronger growth inhibitory effect on Barrett's adenocarcinoma cells than traditional aspirin.
Konturek PC; Kania J; Burnat G; Hahn EG
J Physiol Pharmacol; 2006 Dec; 57 Suppl 12():15-24. PubMed ID: 17244951
[TBL] [Abstract][Full Text] [Related]
14. COX-2 strengthens the effects of acid and bile salts on human esophageal cells and Barrett esophageal cells.
Jiangang S; Nayoung K; Hongfang W; Junda L; Li C; Xuefeng B; Mingsong L
BMC Mol Cell Biol; 2022 Apr; 23(1):19. PubMed ID: 35413817
[TBL] [Abstract][Full Text] [Related]
15. Bile acids induce ectopic expression of intestinal guanylyl cyclase C Through nuclear factor-kappaB and Cdx2 in human esophageal cells.
Debruyne PR; Witek M; Gong L; Birbe R; Chervoneva I; Jin T; Domon-Cell C; Palazzo JP; Freund JN; Li P; Pitari GM; Schulz S; Waldman SA
Gastroenterology; 2006 Apr; 130(4):1191-206. PubMed ID: 16618413
[TBL] [Abstract][Full Text] [Related]
16. Acid and bile salt-induced CDX2 expression differs in esophageal squamous cells from patients with and without Barrett's esophagus.
Huo X; Zhang HY; Zhang XI; Lynch JP; Strauch ED; Wang JY; Melton SD; Genta RM; Wang DH; Spechler SJ; Souza RF
Gastroenterology; 2010 Jul; 139(1):194-203.e1. PubMed ID: 20303354
[TBL] [Abstract][Full Text] [Related]
17. Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
Ishimura N; Amano Y; Sanchez-Siles AA; Fukuhara H; Takahashi Y; Uno G; Tamagawa Y; Mishima Y; Yuki T; Ishihara S; Kinoshita Y
J Clin Gastroenterol; 2011 Sep; 45(8):665-72. PubMed ID: 21325951
[TBL] [Abstract][Full Text] [Related]
18. Bile acids increase levels of microRNAs 221 and 222, leading to degradation of CDX2 during esophageal carcinogenesis.
Matsuzaki J; Suzuki H; Tsugawa H; Watanabe M; Hossain S; Arai E; Saito Y; Sekine S; Akaike T; Kanai Y; Mukaisho K; Auwerx J; Hibi T
Gastroenterology; 2013 Dec; 145(6):1300-11. PubMed ID: 23933602
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of Barrett esophagus: deoxycholic acid up-regulates goblet-specific gene MUC2 in concert with CDX2 in human esophageal cells.
Hu Y; Jones C; Gellersen O; Williams VA; Watson TJ; Peters JH
Arch Surg; 2007 Jun; 142(6):540-4; discussion 544-5. PubMed ID: 17576890
[TBL] [Abstract][Full Text] [Related]
20. Aspirin prevents NF-κB activation and CDX2 expression stimulated by acid and bile salts in oesophageal squamous cells of patients with Barrett's oesophagus.
Huo X; Zhang X; Yu C; Cheng E; Zhang Q; Dunbar KB; Pham TH; Lynch JP; Wang DH; Bresalier RS; Spechler SJ; Souza RF
Gut; 2018 Apr; 67(4):606-615. PubMed ID: 28442495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
